NEWS
View news from our Featured Companies.
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
WINTER SPRINGS, Fla., Feb. 01, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call...
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
$15 million in upfront financing with the potential to receive up to an additional approximately $30 million in potential warrant exercise proceeds for an aggregate of up to approximately $45 million in total gross proceedsEncinitas, California--(January 31, 2024) -...
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clinical Development, Regulatory and Commercial Milestones, Plus Commercial Royalties
Kiora to webcast investor conference call at 5:30 pm today; details belowEncinitas, California and Clermont-Ferrand, France--(January 31, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a clinical-stage biotech company developing treatments for orphan retinal...
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
PONTE VEDRA, Fla., Jan. 31, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist (VKA) for unmet needs in anticoagulation (blood thinning) therapy, cited today a recent peer-reviewed...
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
CARMEL, Ind., Jan. 31, 2024 -- NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced the...
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
PETACH TIKVA, Israel, Jan. 31, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full-year 2023 financial results and...
Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program
Calgary, Alberta--(January 30, 2024) - Greenfire Resources Ltd. (NYSE: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta, Canada,...
ARIANNE PHOSPHATE ADVANCES PREFEASIBILITY STUDY FOR A PURIFIED PHOSPHORIC ACID PLANT
-project would create the largest producer of battery grade acid outside of China DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Jan. 30, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N),...
SenesTech Signs Poppe Enterprises for Evolve™ Distribution in Grain Management Market
PHOENIX, Jan. 29, 2024 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Poppe Enterprises LLC, a distributor and pest management...
ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in...
Scientific Industries Announces Closing of $7.0 Million Private Placement
Proceeds to fund the commercialization of the first multi-parameter sensor for shake flasksBOHEMIA, NY / January 25, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and a developer of digitally simplified bioprocessing products,...
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
CUPERTINO, Calif., Jan. 25, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Mogo to Participate in the KBW Fintech & Payments Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that it will be participating in the KBW Fintech & Payments Conference taking place from February...
Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
PONTE VEDRA, Fla., Jan. 24, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
Modular Medical Announces Issuance of New US Patent
SAN DIEGO, CA / January 24, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
APATITE (PHOSPHATE) ADDED TO THE QUEBEC CRITICAL AND STRATEGIC MINERALS LIST
-announcement will put Arianne Phosphate's Lac à Paul project in focus DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Jan. 24, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a...
Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
GARDNER, Mass., Jan. 23, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will...
LiqTech to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
BALLERUP, Denmark, Jan. 23, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration technologies, will participate in a fireside chat and host one-on-one meetings with investors at the...
SenesTech to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
PHOENIX, Jan. 23, 2024 -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners...
S&W Seed Company to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
LONGMONT, Colo., Jan. 23, 2024 -- S&W Seed Company (Nasdaq: SANW) announced today that Mark Herrmann, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners 2024 Investor Select Conference, taking place...
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
DENVER, CO / January 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a fireside chat and host one-on-one meetings...
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
SAN DIEGO, CA / January 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
Jewett-Cameron Announces 1st Quarter Financial Results
NORTH PLAINS, Ore., Jan. 16, 2024 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the first quarter of fiscal 2024 ended November 30, 2023. Sales for the first quarter of fiscal 2024 totaled $9.8 million compared to sales of...
Reviva to Present at Webull LIVE! Healthcare Webinar on January 17
CUPERTINO, CA / January 10, 2024 / Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging ('MRI") compatible medical devices, today reported...